Hottub News

Novo-Funded Analysis Ties Raising Ozempic to 2 mg to Slightly Lower Heart Risk Than Switching to Mounjaro

2 reports from 2 outlets in 1 language · first reported · updated · JSON

HealthNovoOzempictirzepatide

Reports

  1. Novo Nordisk (NYSE: NVO) Ozempic 2 mg Linked To Lower Heart Attack And Stroke Risk Versus Switching To Mounjaro In Real-World Studyforeignpolicyjournal.com · en ·
  2. Novo-Funded Analysis Ties Raising Ozempic to 2 mg to Slightly Lower Heart Risk Than Switching to Mounjaromedicaldaily.com · en ·

More in Health

  1. Doctors warn about the risks energy drinks pose to kids. What families need to know75 outlets
  2. Lilly's EloraTZP tops Zepbound in mid-stage obesity trial49 outlets
  3. Home Bargains shoppers warned not to eat 2 items as urgent recall issued43 outlets
  4. Florida's dengue outbreak reportedly largest US has seen in decades27 outlets
  5. Alison Hammond provides health update after clutching chest on live television28 outlets
  6. Here's how to find out if you're eligible for Trump's promised $90 Medicare payments18 outlets